Helene Kobbernagel

Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

Helene Kobbernagel, Frederik Buchvald, Eric G. Haarman et al. · The Lancet Respiratory Medicine · 2020 · 132 citations · Full text

Placebo-controlled Phase 3, Antibiotics, Azithromycin Maintenance Therapy +2

Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia

Helene Kobbernagel, Frederik Buchvald, Eric G. Haarman et al. · BMC Pulmonary Medicine · 2016 · 56 citations · Full text

Abbreviation modalities of nitrogen multiple‐breath washout tests in school children with obstructed lung disease

Kent Green, Jacob S. Ejlertsen, Astrid Madsen et al. · Pediatric Pulmonology · 2015 · 30 citations

One-year evolution and variability in multiple-breath washout indices in children and young adults with primary ciliary dyskinesia

Helene Kobbernagel, Kent Green, Astrid Madsen Ring et al. · European Clinical Respiratory Journal · 2019 · 24 citations · Full text

The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN

Johanna Raidt, Bernard Maître, Petra Pennekamp et al. · ERJ Open Research · 2022 · 24 citations · Full text

Translational Medicine, Pulmonary Care, Advanced Lung Disease +10